Various substances in the blood plasma serve as prognostic indicators of the progression of
COVID-19. Consequently, multi-omics studies, such as proteomic and metabolomics, are …

Abnormal cytokine and chemokine concentrations during SARS-CoV-2 infection may
represent disease severity. We aimed to assess plasma cytokine and chemokine …

An excessive inflammatory response to SARS-CoV-2 is thought to be a major cause of
disease severity and mortality in patients with COVID-19. Longitudinal analysis of cytokine …

Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …

Coronavirus disease 2019 (COVID-19) broke out and then became a global epidemic at the
end of 2019. With the increasing number of deaths, early identification of disease severity …

Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly
spread across many other countries. While the majority of patients were considered mild …

Introduction COVID-19 is a viral infection that disturbs the host's immune system and causes
an overproduction of cytokines leading to a cytokine storm. The present study aimed to …

The aims of this study were to analyze cytokine profiles in patients with COVID-19, gain
insights into the immune response during acute infection, identify cytokines associated with …

Background: Identifying immune correlates of COVID-19 disease severity is an urgent need
for clinical management, vaccine evaluation and drug development. Here we present a …

Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …